The redox active MRI contrast agent Fe-PyC3A is shown to provide strong, selective contrast enhancement of acutely inflamed pancreatic tissue in a murine model. Fe-PyC3A is administered in the weakly contrasting Fe(2+) oxidation state but is converted to the 15-fold more strongly contrasting Fe(3+) state in the presence of reactive oxygen species (ROS). Fe-PyC3A does not provide contrast enhancement of normal pancreas, but provides significant contrast enhancement of inflamed pancreas. Pancreatic enhancement correlates tightly with activity levels of the pro-inflammatory biomarker myeloperoxidase. This is the first example of using metal ion redox for MR imaging of pathologic change in vivo.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords